China Edaravone Market Report & Forecast 2021-2027

China Edaravone Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Edaravone Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Edaravone Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Edaravone Overall Market Size
2.1 China Edaravone Market Size: 2021 VS 2027
2.2 China Edaravone Revenue, Prospects & Forecasts: 2016-2027
2.3 China Edaravone Sales: 2016-2027
3 Company Landscape
3.1 Top Edaravone Players in China Market
3.2 Top China Edaravone Companies Ranked by Revenue
3.3 China Edaravone Revenue by Companies
3.4 China Edaravone Sales by Companies
3.5 China Edaravone Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Edaravone Companies in China Market, by Revenue in 2020
3.7 Manufacturers Edaravone Product Type
3.8 Tier 1, Tier 2 and Tier 3 Edaravone Players in China Market
3.8.1 List of Tier 1 Edaravone Companies in China
3.8.2 List of Tier 2 and Tier 3 Edaravone Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Edaravone Market Size Markets, 2021 & 2027
4.1.2 Oral Edaravone
4.1.3 Injection Edaravone
4.2 By Type - China Edaravone Revenue & Forecasts
4.2.1 By Type - China Edaravone Revenue, 2016-2021
4.2.2 By Type - China Edaravone Revenue, 2022-2027
4.2.3 By Type - China Edaravone Revenue Market Share, 2016-2027
4.3 By Type - China Edaravone Sales & Forecasts
4.3.1 By Type - China Edaravone Sales, 2016-2021
4.3.2 By Type - China Edaravone Sales, 2022-2027
4.3.3 By Type - China Edaravone Sales Market Share, 2016-2027
4.4 By Type - China Edaravone Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Edaravone Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - China Edaravone Revenue & Forecasts
5.2.1 By Application - China Edaravone Revenue, 2016-2021
5.2.2 By Application - China Edaravone Revenue, 2022-2027
5.2.3 By Application - China Edaravone Revenue Market Share, 2016-2027
5.3 By Application - China Edaravone Sales & Forecasts
5.3.1 By Application - China Edaravone Sales, 2016-2021
5.3.2 By Application - China Edaravone Sales, 2022-2027
5.3.3 By Application - China Edaravone Sales Market Share, 2016-2027
5.4 By Application - China Edaravone Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Mitsubishi Tanabe Pharma
6.1.1 Mitsubishi Tanabe Pharma Corporation Information
6.1.2 Mitsubishi Tanabe Pharma Overview
6.1.3 Mitsubishi Tanabe Pharma Edaravone Sales and Revenue in China Market (2016-2021)
6.1.4 Mitsubishi Tanabe Pharma Edaravone Product Description
6.1.5 Mitsubishi Tanabe Pharma Recent Developments
6.2 Simcere
6.2.1 Simcere Corporation Information
6.2.2 Simcere Overview
6.2.3 Simcere Edaravone Sales and Revenue in China Market (2016-2021)
6.2.4 Simcere Edaravone Product Description
6.2.5 Simcere Recent Developments
6.3 Taj Pharmaceuticals Ltd.
6.3.1 Taj Pharmaceuticals Ltd. Corporation Information
6.3.2 Taj Pharmaceuticals Ltd. Overview
6.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales and Revenue in China Market (2016-2021)
6.3.4 Taj Pharmaceuticals Ltd. Edaravone Product Description
6.3.5 Taj Pharmaceuticals Ltd. Recent Developments
6.4 Sun Pharmaceutical Industries Ltd.
6.4.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.4.2 Sun Pharmaceutical Industries Ltd. Overview
6.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales and Revenue in China Market (2016-2021)
6.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Description
6.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
6.5 Unichem Laboratories Ltd
6.5.1 Unichem Laboratories Ltd Corporation Information
6.5.2 Unichem Laboratories Ltd Overview
6.5.3 Unichem Laboratories Ltd Edaravone Sales and Revenue in China Market (2016-2021)
6.5.4 Unichem Laboratories Ltd Edaravone Product Description
6.5.5 Unichem Laboratories Ltd Recent Developments
6.6 UCB India Ltd
6.6.1 UCB India Ltd Corporation Information
6.6.2 UCB India Ltd Overview
6.6.3 UCB India Ltd Edaravone Sales and Revenue in China Market (2016-2021)
6.6.4 UCB India Ltd Edaravone Product Description
6.6.5 UCB India Ltd Recent Developments
6.7 Piramal Healthcare
6.7.1 Piramal Healthcare Corporation Information
6.7.2 Piramal Healthcare Overview
6.7.3 Piramal Healthcare Edaravone Sales and Revenue in China Market (2016-2021)
6.7.4 Piramal Healthcare Edaravone Product Description
6.7.5 Piramal Healthcare Recent Developments
7 China Edaravone Production Capacity, Analysis
7.1 China Edaravone Production Capacity, 2016-2027
7.2 Edaravone Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Edaravone Supply Chain Analysis
9.1 Edaravone Industry Value Chain
9.2 Edaravone Upstream Market
9.3 Edaravone Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Edaravone Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Edaravone in China Market
Table 2. Top Edaravone Players in China Market, Ranking by Revenue (2019)
Table 3. China Edaravone Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Edaravone Revenue Share by Companies, 2016-2021
Table 5. China Edaravone Sales by Companies, (K Units), 2016-2021
Table 6. China Edaravone Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Edaravone Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Edaravone Product Type
Table 9. List of Tier 1 Edaravone Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Edaravone Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral Edaravone
Table 12. Major Manufacturers of Injection Edaravone
Table 13. By Type - China Edaravone Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Edaravone Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Edaravone Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Edaravone Sales (K Units), 2016-2021
Table 17. By Type - China Edaravone Sales (K Units), 2022-2027
Table 18. By Application - China Edaravone Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Edaravone Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Edaravone Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Edaravone Sales (K Units), 2016-2021
Table 22. By Application - China Edaravone Sales (K Units), 2022-2027
Table 23. Mitsubishi Tanabe Pharma Corporation Information
Table 24. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 25. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Mitsubishi Tanabe Pharma Edaravone Product
Table 27. Mitsubishi Tanabe Pharma Recent Developments
Table 28. Simcere Corporation Information
Table 29. Simcere Description and Major Businesses
Table 30. Simcere Edaravone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Simcere Edaravone Product
Table 32. Simcere Recent Developments
Table 33. Taj Pharmaceuticals Ltd. Corporation Information
Table 34. Taj Pharmaceuticals Ltd. Description and Major Businesses
Table 35. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Taj Pharmaceuticals Ltd. Edaravone Product
Table 37. Taj Pharmaceuticals Ltd. Recent Developments
Table 38. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 39. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 40. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Sun Pharmaceutical Industries Ltd. Edaravone Product
Table 42. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 43. Unichem Laboratories Ltd Corporation Information
Table 44. Unichem Laboratories Ltd Description and Major Businesses
Table 45. Unichem Laboratories Ltd Edaravone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Unichem Laboratories Ltd Edaravone Product
Table 47. Unichem Laboratories Ltd Recent Developments
Table 48. UCB India Ltd Corporation Information
Table 49. UCB India Ltd Description and Major Businesses
Table 50. UCB India Ltd Edaravone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. UCB India Ltd Edaravone Product
Table 52. UCB India Ltd Recent Developments
Table 53. Piramal Healthcare Corporation Information
Table 54. Piramal Healthcare Description and Major Businesses
Table 55. Piramal Healthcare Edaravone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Piramal Healthcare Edaravone Product
Table 57. Piramal Healthcare Recent Developments
Table 58. Edaravone Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)
Table 59. China Edaravone Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Edaravone Market Opportunities & Trends in China Market
Table 61. Edaravone Market Drivers in China Market
Table 62. Edaravone Market Restraints in China Market
Table 63. Edaravone Raw Materials
Table 64. Edaravone Raw Materials Suppliers in China Market
Table 65. Typical Edaravone Downstream
Table 66. Edaravone Downstream Clients in China Market
Table 67. Edaravone Distributors and Sales Agents in China Market
List of Figures
Figure 1. Edaravone Product Picture
Figure 2. Edaravone Segment by Type
Figure 3. Edaravone Segment by Application
Figure 4. China Edaravone Market Overview: 2020
Figure 5. China Edaravone Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Edaravone Revenue, 2016-2027 (US$, Mn)
Figure 7. Edaravone Sales in China Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Edaravone Revenue in 2020
Figure 9. Oral Edaravone Product Picture
Figure 10. Injection Edaravone Product Picture
Figure 11. By Type - China Edaravone Sales Market Share, 2016-2027
Figure 12. By Type - China Edaravone Revenue Market Share, 2016-2027
Figure 13. By Type - China Edaravone Price (USD/Unit), 2016-2027
Figure 14. Hospital
Figure 15. Clinic
Figure 16. Others
Figure 17. By Application - China Edaravone Sales Market Share, 2016-2027
Figure 18. By Application - China Edaravone Revenue Market Share, 2016-2027
Figure 19. By Application - China Edaravone Price (USD/Unit), 2016-2027
Figure 20. Mitsubishi Tanabe Pharma Edaravone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Simcere Edaravone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Taj Pharmaceuticals Ltd. Edaravone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Sun Pharmaceutical Industries Ltd. Edaravone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Unichem Laboratories Ltd Edaravone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. UCB India Ltd Edaravone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Piramal Healthcare Edaravone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. China Edaravone Production Capacity (K Units), 2016-2027
Figure 28. Edaravone Industry Value Chain
Figure 29. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Narcolepsy Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80

According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......

Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......

Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......

Migraine Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......

Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......

Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......

Global Edaravone Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......

Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......

Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs